New artificial vessels can enter clinical trials to establish invalid shelter shelter after they are introduced | Hong Kong UNWIRE.HK Play. Music Technology

31 March, 2019 • Health, Life Technology •

Maintaining artificial robots is an easy task to maintain in the past, and scientists in the United States have used muscular cells and 3D protein networks to carry out a blood prediction. After a period of exposure to the human body, scientists have discovered that volunteer blood vessels are transformed into a multi-faceted life style similar to tunes. T natural blood, and even after repairing, repair of cells happens.

Humacyte, the USA's medical technology company, has produced a specially-designed human vessel called Acellular Human Vessels, HAV, using biological technology to achieve biomass and better recovery. Scientists use tiny muscular cells of the people and networks of 3D protein to create biased predictions. The protein is removed to form a "cell-free blood vessel".

These 42cm long stainless steel vessels were fitted to 60 patients who needed dialysis in clinical trials. After four years of deliberation, the scientists found out that the blood vessels carried from the cells at the time of the migration could not remove the cells which the patient had had. A sample of 13 people showed that the artificial robot vessels are transformed into introducing a multi-layered lifespan with blood-type umbrellas similar to the world, and there is more signals of the cell revitalization when t will be injured.

The volunteer artificial HAVs did not show an irregular answer compared to artificial blood vessels using polymers. At the moment, it is hoped that thousands of results will be made each year, and in the future, Humacyte does three tests in the United States, Israel and Europe.

Source: Science Translation Translation through TechNews

• Don't miss new technology? Follow FB pageHttp://
• To start with life science and technology ie ie useless resource Https://

Tags: artificial blood vessels

As this article:

Source link